Pharma Stocks
-
Is BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy Now?
Is BCRX a good stock to buy? We came across a bullish thesis on BioCryst Pharmaceuticals, Inc. on BioEquity Watch’s Substack. In…
Read More » -
Pharma and Biotech M&A Boom Accelerates as Companies Expand Pipelines – June 11, 2026
Key Takeaways Johnson & Johnson will buy Firefly Bio for $1B, adding a platform targeting KRAS-driven cancers Lilly struck multiple…
Read More » -
Crinetics Pharmaceuticals (CRNX) is One of the Best AI Driven Biotech Stocks, Here is Why
When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off…
Read More » -
Is It Too Late To Reassess Ligand Pharmaceuticals (LGND) After A 115% One-Year Rally?
If you are wondering whether Ligand Pharmaceuticals at US$248.24 still offers value after a strong run, the next sections will…
Read More » -
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma Company announcement – No. 24 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging…
Read More » -
Parabilis sets a record with a $670M biotech IPO
Dive Brief: Parabilis Medicines, a high-profile startup making medicines for “undruggable” targets, raised $670 million in an initial public offering…
Read More » -
Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, Vedanta
Markets witnessed a volatile session on Tuesday and ended in the green amid mixed cues. Technically, bulls are attempting to…
Read More » -
Healthcare Value Stocks Regain Attention As Market Leadership Shifts
Disclaimer The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos,…
Read More » -
Assessing Tarsus Pharmaceuticals (TARS) Valuation After Recent Share Price Weakness And Strong Longer Term Returns
Tarsus Pharmaceuticals (TARS) has been drawing attention after recent trading swings, with the stock closing at US$59.64 while showing mixed…
Read More » -
Insider Buyers At aTyr Pharma Likely Disappointed With 19% Slide
The recent 19% drop in aTyr Pharma, Inc.’s (NASDAQ:ATYR) stock could come as a blow to insiders who purchased US$911.8k…
Read More »